Auro Laboratories Ltd Financials
Company Logo

Auro Laboratories Ltd Financial Statement

Auro Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue3.41
Operating Expense2.38
Net Profit0.36
Net Profit Margin10.56
Earning Per Share0.57
EBIDTA1.03
Effective Tax Rate11.65
Invest in Auro Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Auro Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual53.64
Operating Expenses Annual42.97
Operating Profit Annual12.17
Interest Annual0.74
Depreciation1.09
Net Profit Annual7.79
Tax Annual2.55

Auro Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning2.42
Cash Flow from Operations18.81
Cash Flow from Investing-38.67
Cash Flow from Financing19.09
Cash Flow at the End1.65

Auro Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)22.71
PBIT Margin (%)20.67
PBT Margin (%)-7.24
Net PROFIT Margin (%)14.52
Return On Networth / Equity (%)20.46
Return On Networth /Employed (%)20.37
Return On Assets (%)14.38
Total Debt / Equity (X)0.43
Asset Turnover Ratio (%)0.99

Auro Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual22.15
Total Current Assets Annual30.85
Non Current Assets Annual54.88
Total Shareholders Funds Annual41.96
Total Assets Annual85.73

Auro Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Auro Laboratories Ltd has a market capitalization of 100.40 Cr. Value Research classifies it as a Micro-Cap company.
No, Auro Laboratories Ltd is not debt-free with a debt-to-equity ratio of 0.63.
In FY 2023 , Auro Laboratories Ltd recorded a total revenue of approximately 53.64 Cr marking a significant milestone in the company's financial performance.
Auro Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.0% annually, respectively..
Auro Laboratories Ltd's current PE ratio is 12.89.
Auro Laboratories Ltd's ROCE averaged 12.4% from the FY ending March 2022 to 2024, with a median of 10.5%. It peaked at 16.2% in March 2024, reflecting strong capital efficiency over the period..
Auro Laboratories Ltd's latest EBIT is Rs. 11.09 Cr, surpassing the average EBIT of Rs. 6.68 Cr over the 5 years..